Used in research and development for immune-related diseases due to its specific targeting of Toll-like receptor 7 (TLR7). It serves as a critical tool in studying autoimmune disorders such as systemic lupus erythematosus (SLE), where TLR7 signaling is implicated in disease progression. By blocking TLR7 activation, this antibody helps modulate abnormal immune responses in experimental models. It is also employed in preclinical studies to evaluate therapeutic strategies for viral infections and cancers, where TLR7 pathways influence immune activation. Its role as a reference antibody makes it valuable for validating assays, screening drug candidates, and standardizing detection methods in immunological research.